Literature DB >> 2826636

Recombinant human interleukin 5 is a selective activator of human eosinophil function.

A F Lopez1, C J Sanderson, J R Gamble, H D Campbell, I G Young, M A Vadas.   

Abstract

Human rIL-5 was found to selectively stimulate morphological changes and the function of human eosinophils. This molecule is thus a prime candidate for the selective eosinophilia and eosinophil activation seen in disease.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2826636      PMCID： PMC2188822          DOI： 10.1084/jem.167.1.219

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  20 in total

1.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

2.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

3.  Comparison of human eosinophils from normals and patients with eosinophilia.

Authors:  D A Bass; W H Grover; J C Lewis; P Szejda; L R DeChatelet; C E McCall
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

4.  The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung.

Authors:  C J Spry; A P Weetman; I Olsson; P C Tai; E G Olsen
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

5.  Large cell carcinoma of the lung associated with marked eosinophilia. A case report.

Authors:  T Kodama; K Takada; T Kameya; Y Shimosato; R Tsuchiya; T Okabe
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

6.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  D Metcalf; C G Begley; G R Johnson; N A Nicola; M A Vadas; A F Lopez; D J Williamson; G G Wong; S C Clark; E A Wang
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

7.  Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.

Authors:  J R David; M A Vadas; A E Butterworth; P A de Brito; E M Carvalho; R A David; J C Bina; Z A Andrade
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

8.  Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.

Authors:  D S Silberstein; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients.

Authors:  D Catovsky; C Bernasconi; P J Verdonck; A Postma; J Hows; A van der Does-van den Berg; J K Rees; G Castelli; E Morra; D A Galton
Journal:  Br J Haematol       Date:  1980-08       Impact factor: 6.998

10.  The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils.

Authors:  T H Howard; C O Oresajo
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539
View more
  171 in total

1.  C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses.

Authors:  T Morokata; J Ishikawa; K Ida; T Yamada
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 2.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

Review 3.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

4.  Clonal expansion of T cells infiltrating in the airways of non-atopic asthmatics.

Authors:  T Umibe; Y Kita; A Nakao; H Nakajima; T Fukuda; S Yoshida; T Sakamaki; Y Saito; I Iwamoto
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 5.  Effects of anti-IgE in asthmatic subjects.

Authors:  A J Frew
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 6.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

7.  Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats.

Authors:  A Haczku; P Macary; T J Huang; H Tsukagoshi; P J Barnes; A B Kay; D M Kemeny; K F Chung; R Moqbel
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

8.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors.

Authors:  J Schmidt; S Fleissner; I Heimann-Weitschat; R Lindstaedt; I Szelenyi
Journal:  Agents Actions       Date:  1994-10

Review 10.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.